We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid Supplementation.
- Authors
MENTING, Stef P.; DEKKER, Paul M.; LIMPENS, Jacqueline; HOOFT, Lotty; SPULS, Phyllis I.
- Abstract
There is a range of methotrexate dosing regimens for psoriasis. This review summarizes the evidence for test-dose, start-dose, dosing scheme, dose adjustments, maximum dose and use of folic acid. A literature search for randomized controlled trials and guidelines was performed. Twenty-three randomized controlled trials (29 treatment groups) and 10 guidelines were included. Two treatment groups used a test-dose, 5 guidelines recommend it. The methotrexate start-dose in randomized controlled trials varied from 5 to 25 mg/week, most commonly being either 7.5 mg or 15 mg. Guidelines vary from 5 to 15 mg/week. Methotrexate was administered as a single dose or in a Weinstein schedule in 15 and 11 treatment groups, respectively; both recommended equally in guidelines. A fixed dose (n = 18), predefined dose (n = 3), or dose adjusted on clinical improvement (n = 8) was used, the last also being recommended in guidelines. Ten treatment groups used folic acid; in 2 it was allowed, in 14 not mentioned, and in 3 no folic acid was used. Most guidelines recommend the use of folic acid. Authors' suggestions for methotrexate dosing are given.
- Subjects
METHOTREXATE; DRUG dosage; PSORIASIS treatment; FOLIC acid; RANDOMIZED controlled trials
- Publication
Acta Dermato-Venereologica, 2016, Vol 96, Issue 1, p23
- ISSN
0001-5555
- Publication type
Article
- DOI
10.2340/00015555-2081